MetLife Investment Management LLC Sells 66 Shares of Inspire Medical Systems, Inc. (NYSE:INSP)

MetLife Investment Management LLC lowered its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 3.5% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,846 shares of the company’s stock after selling 66 shares during the quarter. MetLife Investment Management LLC’s holdings in Inspire Medical Systems were worth $390,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. AQR Capital Management LLC grew its position in shares of Inspire Medical Systems by 152.7% during the 2nd quarter. AQR Capital Management LLC now owns 231,845 shares of the company’s stock valued at $31,028,000 after acquiring an additional 140,090 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new position in Inspire Medical Systems during the third quarter valued at $1,929,000. SG Americas Securities LLC increased its position in Inspire Medical Systems by 114.2% in the second quarter. SG Americas Securities LLC now owns 6,228 shares of the company’s stock worth $833,000 after buying an additional 3,321 shares during the last quarter. Thrivent Financial for Lutherans raised its stake in shares of Inspire Medical Systems by 39.7% in the third quarter. Thrivent Financial for Lutherans now owns 110,580 shares of the company’s stock valued at $23,337,000 after buying an additional 31,444 shares during the period. Finally, Headlands Technologies LLC purchased a new position in shares of Inspire Medical Systems during the 2nd quarter valued at $1,391,000. Institutional investors own 94.91% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on INSP shares. Piper Sandler reaffirmed an “overweight” rating and set a $260.00 price objective (up from $255.00) on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Bank of America raised shares of Inspire Medical Systems from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $220.00 to $255.00 in a report on Wednesday, November 20th. Robert W. Baird increased their target price on Inspire Medical Systems from $240.00 to $252.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 5th. Truist Financial reiterated a “buy” rating and issued a $240.00 price target (up from $217.00) on shares of Inspire Medical Systems in a research report on Monday, September 30th. Finally, Wells Fargo & Company increased their price objective on Inspire Medical Systems from $187.00 to $198.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 5th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $233.58.

Inspire Medical Systems Price Performance

INSP stock opened at $193.03 on Monday. The firm has a 50 day simple moving average of $196.36 and a two-hundred day simple moving average of $177.71. The stock has a market cap of $5.79 billion, a PE ratio of 180.40 and a beta of 1.31. Inspire Medical Systems, Inc. has a one year low of $123.00 and a one year high of $257.40.

Inspire Medical Systems (NYSE:INSP) last announced its earnings results on Monday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.54. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The company had revenue of $203.20 million during the quarter, compared to analyst estimates of $197.59 million. During the same period in the previous year, the business earned ($0.29) earnings per share. The firm’s quarterly revenue was up 32.6% compared to the same quarter last year. On average, research analysts expect that Inspire Medical Systems, Inc. will post 1.33 EPS for the current fiscal year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.